Conference
Neovastat (Æ-941) in addition to combined modality therapy for locally-advanced unresectable non-small cell lung cancer (NSCLC):: An NCI-sponsored multicenter phase III study.
Authors
Evans WK; Champagne P; Falardeau P; Hariton C; Dupont É
Volume
7
Pagination
pp. 3659S-3659S
Publisher
AMER ASSOC CANCER RESEARCH
Publication Date
November 1, 2001
Conference proceedings
CLINICAL CANCER RESEARCH
Issue
11
ISSN
1078-0432